Analyst Research
| Report Title | Price |
|---|---|
|
Provider: S&P Capital IQ – STARS Reports
|
$115.00
|
|
Provider: Pechala's Reports
|
$15.00
|
|
Provider: Reuters Investment Profile
|
$20.00
|
|
Provider: Thomson Reuters Stock Report
|
$25.00
|
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
Glaxosmithkline Plc Declares Dividend
Glaxosmithkline Plc announced that the Board has declared a second interim dividend of GBP0.17 per share (Q2 2011: GBP0.16 per share) making GBP34 for the half year. The equivalent interim dividend receivable by ADR holders is 52.7918 cents per ADS based on an exchange rate of GBP1/$1.5527. The ex-dividend date will be August 8, 2012, with a record date of August 10 and a payment date of October 4, 2012.
Latest Developments for GlaxoSmithKline PLC
- Elan Corporation PLC Strikes $1 Billion GlaxoSmithKline Plc Royalty Deal With Theravance Inc-Reuters
- FDA Approves Glaxosmithkline Plc's Breo Ellipta To Treat Lung Disease Jointly Developed With Theravance Inc-DJ
- Glaxosmithkline Plc Opts To Sell Off Lucozade And Ribena Drink Brands-Reuters
- Glaxosmithkline Plc Reaffirms FY 2013 Guidance; Declares First Interim Dividend
Latest Key Developments in Pharmaceuticals
- H Lundbeck A/S and Takeda Pharmaceutical Company Limited's Vortioxetine Clinical Phase III Data Show Improvement in Symptoms of Major Depression
- Jiangsu Hengrui Medicine Co Ltd Receives FDA Approval
- NanJing Pharmaceutical Co Ltd to Acquire Equity Shares
- AmerisourceBergen Corp Reaffirms FY 2013 EPS Gudiance-Conference Call
- Share this
- Link this
- Digg this
Follow Reuters